Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)

 PRIO_RABIT              Reviewed;         252 AA.
01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
01-FEB-1997, sequence version 1.
07-NOV-2018, entry version 134.
RecName: Full=Major prion protein;
AltName: Full=PrP27-30;
AltName: Full=PrP33-35C;
AltName: CD_antigen=CD230;
Flags: Precursor;
Name=PRNP; Synonyms=PRP;
Oryctolagus cuniculus (Rabbit).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
STRAIN=New Zealand white;
PubMed=9031631; DOI=10.1016/S0378-1119(96)00598-7;
Loftus B., Rogers M.;
"Characterization of a prion protein (PrP) gene from rabbit; a species
with apparent resistance to infection by prions.";
Gene 184:215-219(1997).
PubMed=20639199; DOI=10.1074/jbc.M110.118844;
Wen Y., Li J., Yao W., Xiong M., Hong J., Peng Y., Xiao G., Lin D.;
"Unique structural characteristics of the rabbit prion protein.";
J. Biol. Chem. 285:31682-31693(2010).
-!- FUNCTION: Its primary physiological function is unclear. Has
cytoprotective activity against internal or environmental
stresses. May play a role in neuronal development and synaptic
plasticity. May be required for neuronal myelin sheath
maintenance. May play a role in iron uptake and iron homeostasis.
Soluble oligomers are toxic to cultured neuroblastoma cells and
induce apoptosis (in vitro). Association with GPC1 (via its
heparan sulfate chains) targets PRNP to lipid rafts. Also provides
Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
degradation of its heparan sulfate side chains (By similarity).
{ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
-!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
amyloid fibrils containing a cross-beta spine, formed by a steric
zipper of superposed beta-strands. Soluble oligomers may represent
an intermediate stage on the path to fibril formation. Copper
binding may promote oligomerization. Interacts with GRB2, APP,
ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
interacts with MGRN1; this interaction alters MGRN1 subcellular
location and causes lysosomal enlargement. Interacts with
KIAA1191. {ECO:0000250|UniProtKB:P04156,
Self; NbExp=2; IntAct=EBI-15889930, EBI-15889930;
{ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
{ECO:0000250|UniProtKB:P04156}. Golgi apparatus
{ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
association with the heparan sulfate chains of GPC1. Colocates, in
the presence of Cu(2+), to vesicles in para- and perinuclear
regions, where both proteins undergo internalization. Heparin
displaces PRNP from lipid rafts and promotes endocytosis.
-!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
structure. The disease-associated, protease-resistant form forms
amyloid fibrils containing a cross-beta spine, formed by a steric
zipper of superposed beta-strands. Disease mutations may favor
intermolecular contacts via short beta strands, and may thereby
trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
-!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
At low copper concentrations, the sidechains of His residues from
three or four repeats contribute to the binding of a single copper
ion. Alternatively, a copper ion can be bound by interaction with
the sidechain and backbone amide nitrogen of a single His residue.
The observed copper binding stoichiometry suggests that two repeat
regions cooperate to stabilize the binding of a single copper ion.
At higher copper concentrations, each octamer can bind one copper
ion by interactions with the His sidechain and Gly backbone atoms.
A mixture of binding types may occur, especially in the case of
octamer repeat expansion. Copper binding may stabilize the
conformation of this region and may promote oligomerization.
-!- DISEASE: Note=Found in high quantity in the brain of humans and
animals infected with degenerative neurological diseases such as
kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
-!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
EMBL; U28334; AAC48697.1; -; Genomic_DNA.
PIR; JC6175; JC6175.
RefSeq; XP_008254357.1; XM_008256135.2.
RefSeq; XP_008254358.1; XM_008256136.2.
UniGene; Ocu.6364; -.
PDB; 2FJ3; NMR; -; A=91-228.
PDB; 2JOH; NMR; -; A=91-228.
PDB; 2JOM; NMR; -; A=91-228.
PDB; 4HLS; X-ray; 1.45 A; A/B=119-229.
PDB; 4HMM; X-ray; 1.50 A; A/B=119-229.
PDB; 4HMR; X-ray; 1.60 A; A/B=119-229.
PDBsum; 2FJ3; -.
PDBsum; 2JOH; -.
PDBsum; 2JOM; -.
PDBsum; 4HLS; -.
PDBsum; 4HMM; -.
PDBsum; 4HMR; -.
ProteinModelPortal; Q95211; -.
SMR; Q95211; -.
DIP; DIP-59794N; -.
STRING; 9986.ENSOCUP00000001797; -.
PRIDE; Q95211; -.
Ensembl; ENSOCUT00000002082; ENSOCUP00000001797; ENSOCUG00000002086.
GeneID; 100008658; -.
CTD; 5621; -.
eggNOG; ENOG410IJMM; Eukaryota.
GeneTree; ENSGT00510000049083; -.
HOVERGEN; HBG008260; -.
InParanoid; Q95211; -.
OrthoDB; EOG091G0HMV; -.
TreeFam; TF105188; -.
EvolutionaryTrace; Q95211; -.
Proteomes; UP000001811; Chromosome 4.
Bgee; ENSOCUG00000002086; Expressed in 3 organ(s), highest expression level in prefrontal cortex.
GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
GO; GO:0009986; C:cell surface; IEA:Ensembl.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0030425; C:dendrite; IEA:Ensembl.
GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
GO; GO:0016234; C:inclusion body; IEA:Ensembl.
GO; GO:0045121; C:membrane raft; IEA:Ensembl.
GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0001540; F:amyloid-beta binding; IEA:Ensembl.
GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
GO; GO:1903135; F:cupric ion binding; IEA:Ensembl.
GO; GO:1903136; F:cuprous ion binding; IEA:Ensembl.
GO; GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl.
GO; GO:0042802; F:identical protein binding; IPI:IntAct.
GO; GO:0008017; F:microtubule binding; IEA:Ensembl.
GO; GO:0002020; F:protease binding; IEA:Ensembl.
GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
GO; GO:0038023; F:signaling receptor activity; IEA:Ensembl.
GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IEA:Ensembl.
GO; GO:0032147; P:activation of protein kinase activity; IEA:Ensembl.
GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IEA:Ensembl.
GO; GO:1904646; P:cellular response to amyloid-beta; IEA:Ensembl.
GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
GO; GO:0007611; P:learning or memory; IEA:Ensembl.
GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
GO; GO:1902430; P:negative regulation of amyloid-beta formation; IEA:Ensembl.
GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
GO; GO:1902951; P:negative regulation of dendritic spine maintenance; IEA:Ensembl.
GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.
GO; GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl.
GO; GO:0032700; P:negative regulation of interleukin-17 production; IEA:Ensembl.
GO; GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl.
GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl.
GO; GO:1990535; P:neuron projection maintenance; IEA:Ensembl.
GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IEA:Ensembl.
GO; GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl.
GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IEA:Ensembl.
GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
GO; GO:1905664; P:regulation of calcium ion import across plasma membrane; IEA:Ensembl.
GO; GO:1900449; P:regulation of glutamate receptor signaling pathway; IEA:Ensembl.
GO; GO:1902938; P:regulation of intracellular calcium activated chloride channel activity; IEA:Ensembl.
GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IEA:Ensembl.
GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
Gene3D; 1.10.790.10; -; 1.
InterPro; IPR000817; Prion.
InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
InterPro; IPR020949; Prion_copper_b_octapeptide.
InterPro; IPR025860; Prion_N_dom.
PANTHER; PTHR10502:SF134; PTHR10502:SF134; 1.
Pfam; PF00377; Prion; 1.
Pfam; PF11587; Prion_bPrPp; 1.
Pfam; PF03991; Prion_octapep; 5.
SMART; SM00157; PRP; 1.
SUPFAM; SSF54098; SSF54098; 1.
PROSITE; PS00291; PRION_1; 1.
PROSITE; PS00706; PRION_2; 1.
1: Evidence at protein level;
3D-structure; Amyloid; Cell membrane; Complete proteome; Copper;
Disulfide bond; Glycoprotein; Golgi apparatus; GPI-anchor;
Lipoprotein; Membrane; Metal-binding; Prion; Reference proteome;
Repeat; Signal; Zinc.
SIGNAL 1 28 {ECO:0000255}.
CHAIN 29 229 Major prion protein.
PROPEP 230 252 Removed in mature form. {ECO:0000255}.
REPEAT 51 59 1.
REPEAT 60 67 2.
REPEAT 68 75 3.
REPEAT 76 83 4.
REPEAT 84 92 5.
REGION 23 229 Interaction with GRB2, ERI3 and SYN1.
REGION 51 92 5 X 8 AA tandem repeats of P-H-G-G-G-W-G-
METAL 61 61 Copper or zinc 1.
METAL 62 62 Copper or zinc 1; via amide nitrogen.
METAL 63 63 Copper or zinc 1; via amide nitrogen and
carbonyl oxygen.
METAL 69 69 Copper or zinc 2.
METAL 70 70 Copper or zinc 2; via amide nitrogen.
METAL 71 71 Copper or zinc 2; via amide nitrogen and
carbonyl oxygen.
METAL 77 77 Copper or zinc 3.
METAL 78 78 Copper or zinc 3; via amide nitrogen.
METAL 79 79 Copper or zinc 3; via amide nitrogen and
carbonyl oxygen.
METAL 85 85 Copper or zinc 4.
METAL 86 86 Copper or zinc 4; via amide nitrogen.
METAL 87 87 Copper or zinc 4; via amide nitrogen and
carbonyl oxygen.
LIPID 229 229 GPI-anchor amidated alanine.
CARBOHYD 180 180 N-linked (GlcNAc...) asparagine.
CARBOHYD 196 196 N-linked (GlcNAc...) asparagine.
DISULFID 178 213 {ECO:0000269|PubMed:20639199}.
STRAND 128 130 {ECO:0000244|PDB:2FJ3}.
TURN 131 134 {ECO:0000244|PDB:2JOH}.
HELIX 143 152 {ECO:0000244|PDB:4HLS}.
HELIX 153 155 {ECO:0000244|PDB:4HLS}.
STRAND 161 163 {ECO:0000244|PDB:4HMM}.
HELIX 165 167 {ECO:0000244|PDB:4HLS}.
HELIX 171 191 {ECO:0000244|PDB:4HLS}.
TURN 192 194 {ECO:0000244|PDB:4HLS}.
HELIX 199 220 {ECO:0000244|PDB:4HLS}.
HELIX 222 228 {ECO:0000244|PDB:4HLS}.
SEQUENCE 252 AA; 27432 MW; 2E177AAF38B23A54 CRC64;

Related products :

Catalog number Product name Quantity
20-272-190924 Prion protein PrP - Mouse monoclonal [WD3C7] to Prion protein PrP; PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen Monoclonal 0.1 mg
20-272-191016 Prion protein PrP - Mouse monoclonal [7D9] to Prion protein PrP; PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen Monoclonal 0.1 ml
18-272-196859 Prion protein PrP - Rabbit polyclonal to Prion protein PrP; PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen Polyclonal 0.05 ml
EIAAB32381 Major prion protein,Mouse,Mus musculus,Prnp,Prn-p,PrP,Prp,PrP27-30,PrP33-35C
EIAAB32377 Major prion protein,Oryctolagus cuniculus,PRNP,PrP,PRP,PrP27-30,PrP33-35C,Rabbit
EIAAB32378 ASCR,Homo sapiens,Human,Major prion protein,PRIP,PRNP,PrP,PRP,PrP27-30,PrP33-35C
20-783-74607 MOUSE ANTI PRION PROTEIN - PrP; Major scrapie-associated fibril protein 1; CD230 antigen Monoclonal 0.1 mg
11-593-C100 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a 0.1 mg
11-593-C025 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a 0.025 mg
1A-315-T025 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Species Reactivity Human Negative Species Clone MEM_238 Isotype IgG1 Application FC, WB Immunogen 25 tests
A6-315-T100 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Species Reactivity Human Negative Species Clone MEM_238 Isotype IgG1 Application FC, WB Immunogen 100 tests
C164 Recombinant Human Major Prion Protein per PRP per CD230 10ug
18-783-76346 GOAT ANTI HUMAN PRION PROTEIN (CD230) - PRION PROTEIN; Polyclonal 0.1 ml
18-783-76347 GOAT ANTI HUMAN PRION PROTEIN (CD230) - PRION PROTEIN; Polyclonal 0.01 ml
Y104847 Prion protease-resistant protein, 27-30 (PrP27-30), N-Terminal Antibody 100 ul
Y105312 Prion protease-resistant protein, 27-30 (PrP27-30), N-Terminal Antibody 250ul
GWB-8D9823 Anti- Prion protease-resistant protein 27-30 (PrP27-30) N-Terminal Antibody
GWB-92178F Anti- Prion protease-resistant protein 27-30 (PrP27-30) N-Terminal Antibody
EIAAB32380 Bos taurus,Bovine,Major prion protein,Major scrapie-associated fibril protein 1,PRNP,PrP,PRP
11-593-C025 CD230 _ Human Prion Protein (PrP) 0.025 mg
11-593-C100 CD230 _ Human Prion Protein (PrP) 0.1 mg
YSRTAHP498 CD230, Prion Protein, Goat anti_Human 0.1 ml.
YSRTAHP498T CD230, Prion Protein, Goat anti_Human 0.02 ml.
11-593-C025 Mouse Monoclonal to CD230 Human Prion Protein (PrP) 0.025 mg
bs-11788R Rabbit Anti-Prion protein PrP-CD230 Polyclonal Antibody 100ul


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur

Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur